The Annual Report can be accessed on Takeda's website at: https://www.takeda.com/investors/sec-filings-and-security-reports/.
In addition, Takeda will also provide a hard copy of the Annual Report, which includes its most recent complete audited financial statements free of charge to any shareholder upon request.
About Takeda
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in
Contact:
Tel: +81-3-3278-2111
Fax: +81-3-3278-2000
Tel: +81-6-6204-2111
Fax: +81-6-6204-2880
(C) 2024 Electronic News Publishing, source